PharmaIN

About:

PharmaIN is a development stage biopharmaceutical company,

Description:

PharmaIN is a development stage biopharmaceutical company focused on enabling and improving injectable therapeutics based on the Protected Graft Copolymer (PGC™), our patented and proprietary drug delivery technology licensed from Massachusetts General Hospital. We are focused on half-life extension and targeted delivery of proteins, peptides, siRNA, and potent small molecule therapeutics.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2001-01-01

Contact Email:

contactus(AT)pharmain.com

Founders:

Elijah M. Bolotin

Number of Employees:

11-50

Last Funding Date:

2014-05-16

IPO Status:

Private

Industries: